Patents by Inventor Boris Seletsky

Boris Seletsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazoazepinone compounds
    Patent number: 7985746
    Abstract: The invention relates to compounds of formula I: along with pharmaceutical compositions containing the same and methods of use thereof for the treatment of autoimmune disease.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: July 26, 2011
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Francis Fang, Shawn Schiller, Boris Seletsky, Mark Spyvee
  • IMIDAZOAZEPINONE COMPOUNDS
    Publication number: 20090233906
    Abstract: The invention relates to compounds of formula (I): along with pharmaceutical compositions containing the same and methods of use thereof.
    Type: Application
    Filed: May 23, 2007
    Publication date: September 17, 2009
    Inventors: Francis Fang, Shawn Schiller, Boris Seletsky, Mark Spyvee
  • IMIDAZOAZEPINONE COMPOUNDS
    Publication number: 20090131405
    Abstract: The invention relates to compounds of formula I: along with pharmaceutical compositions containing the same and methods of use thereof for the treatment of autoimmune disease.
    Type: Application
    Filed: May 24, 2007
    Publication date: May 21, 2009
    Inventors: Francis Fang, Shawn Schiller, Boris Seletsky, Mark Spyvee
  • Deazapurines and uses thereof
    Publication number: 20080103137
    Abstract: As discussed above, there remains a need for the development of novel therapeutic agents useful for treating inflammatory or autoimmune and proliferative diseases.
    Type: Application
    Filed: September 28, 2007
    Publication date: May 1, 2008
    Inventors: Jane Daun, Heather Davis, Bruce DeCosta, Fabian Gusovsky, Ieharu Hishinuma, Yimin Jiang, Toshihiko Kaneko, Kouichi Kikuchi, Seiichi Kobayashi, Andre Lescarbeau, Xiang-Yi Li, Kenzo Muramoto, Norihito Ohi, Marc Pesant, Boris Seletsky, Motohiro Soejima, Mark Spyvee, Lynda Tremblay, Ye Yao, Hiromitsu Yokohama, Yan (Janet) Zhao, Wanjun Zheng
  • Hemiasterlin derivatives and uses thereof in the treatment of cancer
    Publication number: 20080051434
    Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
    Type: Application
    Filed: February 2, 2007
    Publication date: February 28, 2008
    Applicant: EISAI CO., LTD.
    Inventors: James Kowalczyk, Galina Kuznetsov, Shawn Schiller, Boris Seletsky, Mark Spyvee, Hu Yang
  • Hemiasterlin derivatives and uses thereof
    Publication number: 20060154872
    Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
    Type: Application
    Filed: January 26, 2006
    Publication date: July 13, 2006
    Inventors: Silvio Campagna, Francis Fang, James Kowalczyk, Shawn Schiller, Boris Seletsky, Mark Spyvee, Hu Yang
  • Hrmiasterlin derivatives and uses thereof
    Publication number: 20050239870
    Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
    Type: Application
    Filed: March 21, 2003
    Publication date: October 27, 2005
    Applicant: EISAI CO., LTD.,
    Inventors: James Kowalczyk, Galina Kuznetsov, Shawn Schiller, Boris Seletsky, Mark Spyvee, Hu Yang
  • Deazapurines and uses thereof
    Publication number: 20050124649
    Abstract: The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally.
    Type: Application
    Filed: January 7, 2003
    Publication date: June 9, 2005
    Applicant: EISAI CO., LTD
    Inventors: Jane Daun, Heather Davis, Bruce DeAcosta, Fabian Gusovsky, Ieharu Hishinuma, Yimin Jiang, Toshihiko Kaneko, Kouichi Kikuchi, Seiichi Kobayashi, Andre Lescarbeau, Xiang-Yi Li, Kenzo Muramoto, Norihito Ohi, Marc Pesant, Boris Seletsky, Mark Spyvee, Lynda Tremblay, Ye Yao, Hiromitsu Yokohama, Yan (Janet) Zhao, Wanjun Zheng